Reduced binding of [3H]ketanserin to cortical 5-ht2 receptors in senile dementia of the Alzheimer type.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Neuroscience Letters

• Publication date

  1984-01-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0304-3940(84)90219-2PMID 6717852
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Loss of pigmented dopamine-β-hydroxylase positive cells from locus coeruleus in senile dementia of alzheimer's type

  1983cited by this paper
• Serotonin nerve cells in Alzheimer's disease.

  1983cited by this paper
• Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease

  1983cited by this paper
• Intact 5HT neuroterminals are not required for 5HT2 receptor down-regulation by amitriptyline.

  1982cited by this paper
• Neurotransmitters and CNS disease. Dementia.

  1982cited by this paper
• Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia

  1982cited by this paper
• [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.

  1982cited by this paper
• The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes.

  1982cited by this paper
• A post-mortem study of the cholinergic and GABA systems in senile dementia.

  1982cited by this paper
• Multiple serotonin receptors: regional distribution and effect of Raphe lesions.

  1981cited by this paper
• Two distinct central serotonin receptors with different physiological functions.

  1981cited by this paper
• Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia.

  1981cited by this paper
• Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

  1981cited by this paper
• Cholinergic deficit in frontal cerebral cortex in Alzheimer's disease is age dependent.

  1981cited by this paper
• Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type.

  1980cited by this paper
• The cholinergic system in Alzheimer's disease

  1980cited by this paper
• An analysis of factors influencing measurements of dopamine, noradrenaline, glutamate decarboxylase and choline acetylase in human post-mortem brain tissue.

  1979cited by this paper
• Changes in the Brain Catecholamines in Patients with Dementia of Alzheimer Type

  1979cited by this paper
• The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects

  1968cited by this paper

• Insights into the development of 99mTc-radioligands for serotonergic receptors imaging: Synthesis, labeling, In vitro, and In vivo studies.

  2024cites this paper
• Interactions of Hallucinogens with the Glutamatergic System: Permissive Network Effects Mediated Through Cortical Layer V Pyramidal Neurons.

  2018cites this paper
• Differential effects of amyloid-beta 1-40 and 1-42 fibrils on 5-HT1A serotonin receptors in rat brain.

  2016cites this paper
• Psychedelics

  2016cites this paper
• Imaging of Neurotransmitter Systems in Dementia

  2016cites this paper
• When is a Proof-of-Concept (POC) not a POC? Pomaglumetad (LY2140023) as a Case Study for Antipsychotic Efficacy.

  2015cites this paper
• Effects of amyloid-β peptides on the serotoninergic 5-HT1A receptors in the rat hippocampus.

  2011cites this paper
• Major depression, cognitive dysfunction and Alzheimer's disease: is there a link?

  2010cites this paper
• Preliminary in vivo and ex vivo evaluation of the 5-HT2A imaging probe [(18)F]MH.MZ.

  2009cites this paper
• Vers l'imagerie TEP de la neurotransmission sérotoninergique dans la maladie d'Alzheimer : du radiotraceur au modèle animal.

  2008cites this paper
• Reduced 5-HT2A receptor binding in patients with mild cognitive impairment.

  2008cites this paper
• A review of the literature on neuroimaging of serotoninergic function in Alzheimer’s disease and related disorders

  2007cites this paper
• Age-related behavioural, neurochemical and radioligand binding changes in the central 5-HT system of Sprague-Dawley rats

  2005cites this paper
• Serotonin, Kognition, Demenz

  2005cites this paper
• Monoamine neurons in aging and Alzheimer's disease

  2005cites this paper
• Serotoninergic impairment and aggressive behavior in Alzheimer's disease.

  2005cites this paper
• Functional neurochemistry of Alzheimer's disease.

  2004cites this paper
• Nucleus raphe dorsalis in parkinsonism-dementia complex of Guam

  2004cites this paper
• Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition

  2004cites this paper
• Radiosynthesis and in vitro evaluation of the 5HT2 receptor ligand [N-11C-methyl]-1-[2,5-dimethoxy-4-iodophenyl]-2-methylaminopropane for PET

  2004cites this paper
• Intraventricular 5,7-dihydroxytryptamine lesions disrupt acquisition of working memory task rules but not performance once learned.

  2003cites this paper
• Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease.

  2003cites this paper
• Assessment of neuroreceptor changes in healthy ageing and in Alzheimer's disease with emission tomography

  2003cites this paper
• Dynamic Neurotransmitter Interactions Measured with PET

  2001cites this paper
• Mapping of 5‐HT2A receptors and their mRNA in monkey brain: [3H]MDL100,907 autoradiography and in situ hybridization studies

  2001cites this paper
• PET quantification of 5-HT2A receptors in the human brain: a constant infusion paradigm with [18F]altanserin.

  2000cites this paper
• Serotonin 5-HT2A Receptor Binding in Platelets From Patients With Alzheimer's Disease or Vascular Dementia

  2000cites this paper
• Equilibrium modeling of 5-HT(2A) receptors with [18F]deuteroaltanserin and PET: feasibility of a constant infusion paradigm.

  2000cites this paper
• Neurochemical alterations in schizophrenia affecting the putative receptor targets of atypical antipsychotics

  1999cites this paper
• The effects of female sex steroids on central serotonergic neurotransmission

  1999cites this paper
• What are we measuring with PET?

  1998cites this paper
• 123I-5-I-R91150, a new single-photon emission tomography ligand for 5-HT2A receptors: influence of age and gender in healthy subjects

  1998cites this paper
• Serotonin in Aging, Late-Life Depression, and Alzheimer's Disease: The Emerging Role of Functional Imaging

  1998cites this paper
• Serotonin-immune interactions in elderly volunteers and in patients with Alzheimer’s disease (DAT): Lower plasma tryptophan availability to the brain in the elderly and increased serum interleukin-6 in DAT

  1998cites this paper
• [3H]MDL 100,907 labels 5-HT2A serotonin receptors selectively in primate brain.

  1998cites this paper
• Imaging of cholinergic terminals using the radiotracer [18F](+)‐4‐fluorobenzyltrozamicol: In vitro binding studies and positron emission tomography studies in nonhuman primates

  1997cites this paper
• Preclinical evaluation of [123I]R93274 as a SPECT radiotracer for imaging 5-HT2A receptors.

  1997cites this paper
• The neurochemistry of Alzheimer's disease.

  1997cites this paper
• Regional Differences of Serotonin-Mediated Synaptic Plasticity in the Chicken Spinal Cord With Development and Aging

  1997cites this paper
• Molecular Neurobiology of Alzheimer's Disease (Syndrome?)

  1997cites this paper
• Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.

  1996cites this paper
• Technetium(V) and rhenium(V) complexes for 5-HT2A serotonin receptor binding: structure-affinity considerations.

  1996cites this paper
• The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared.

  1996cites this paper
• Pharmacotherapy of Cognitive Impairment in Alzheimer's Disease: A Review

  1995cites this paper
• The treatment of Alzheimer's disease

  1995cites this paper
• Serotonergic Regulation of Acetylcholine Release in Rat Frontal Cortex

  1995cites this paper
• Serotonergic modulation of cholinergic function in the central nervous system: cognitive implications.

  1995cites this paper
• Serotonin 5HT2 Receptor Imaging in the Human Brain Using Positron Emission Tomography and a New Radioligand, [18F]Altanserin: Results in Young Normal Controls

  1995cites this paper
• Serotonin and human myoclonus. Rationale for the use of serotonin receptor agonists and antagonists.

  1994cites this paper
• Modulatory function of serotonin in rat neocortex: 5-HT2A and N-methyl-D-aspartate receptor interactions

  1994cites this paper
• Abnormalities in Non-Cholinergic Neurotransmitter Systems in Alzheimer’s Disease

  1994cites this paper
• Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone.

  1993cites this paper
• Is ammonia a pathogenetic factor in Alzheimer's disease?

  1993cites this paper
• Effect of aging in human cortical pre- and postsynaptic serotonin binding sites.

  1993cites this paper
• Monoaminergic Innervation of Cingulate Cortex

  1993cites this paper
• Neurotransmitter receptors in Alzheimer disease.

  1993cites this paper
• Therapeutic intervention in dementia.

  1993cites this paper
• Autoradiographic localization of serotonin receptor subtypes in cat visual cortex: transient regional, laminar, and columnar distributions during postnatal development

  1993cites this paper
• 5-Hydroxytryptamine receptors.

  1992cites this paper
• TRH protection against memory retrieval deficits is independent of endocrine effects.

  1992cites this paper
• Monoamine neurotransmitters and their metabolites in brain regions in alzheimer's disease: A postmortem study

  1992cites this paper
• Neurochemical Changes with Aging: Predisposition toward Age-Related Mental Disorders

  1992cites this paper
• Neurotransmitter, receptor and signal transduction disturbances in Alzheimer's disease

  1992cites this paper
• Neuroreceptor changes in Alzheimer disease.

  1992cites this paper
• Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms

  1992cites this paper
• Alzheimer's disease: specific increases in a G protein subunit (Gs alpha) mRNA in hippocampal and cortical neurons.

  1991cites this paper
• Laminar alterations in gamma-aminobutyric acidA, muscarinic, and beta adrenoceptors and neuron degeneration in cingulate cortex in Alzheimer's disease.

  1991cites this paper
• Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases.

  1991cites this paper
• The effect of ondansetron on cognitive performance in the marmoset.

  1991cites this paper
• Laminar Alterations in γ‐Aminobutyric AcidA, Muscarinic, and β Adrenoceptors and Neuron Degeneration in Cingulate Cortex in Alzheimer's Disease

  1991cites this paper
• Fluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats.

  1991cites this paper
• Neurotransmitters, neuroreceptors and aging.

  1991cites this paper
• Imaging the Serotonergic System by Positron Emission Tomography

  1990cites this paper
• Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.

  1990cites this paper
• Alzheimer's disease: Changes in hippocampal N-methyl-d-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors—an autoradiographic study

  1990cites this paper
• Selective alterations of high affinity [3H]forskolin binding sites in Alzheimer's disease: a quantitative autoradiographic study.

  1990cites this paper
• Serotonin in Alzheimer‐type Dementia and Other Dementing Illnesses

  1990cites this paper
• 5HT2 receptors in dementia of the Alzheimer type: A quantitative autoradiographic study of frontal cortex and hippocampus

  1990influential citation
• Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes and subsystems.

  1990cites this paper
• Implications of multiple transmitter system lesions for cholinomimetic therapy in Alzheimer's disease.

  1990cites this paper
• A Method for the In Vivo Investigation of the Serotonergic 5‐HT2 Receptors in the Human Cerebral Cortex Using Positron Emission Tomography and 18F‐Labeled Setoperone

  1990cites this paper
• 5 HT2 receptors in dementia of Alzheimer type: a quantitative autoradiographic study of frontal cortex and hippocampus.

  1990cites this paper
• Aging and Alzheimer's disease. Altered cortical serotonergic binding.

  1989cites this paper
• Common receptors for hallucinogens in rat brain: a comparative autoradiographic study using [125I]LSD and [125I]DOI, a new psychotomimetic radioligand.

  1989cites this paper
• Biogenic amines and their metabolites in Alzheimer's disease: noradrenaline, 5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid depleted in hippocampus but not in substantia innominata.

  1989cites this paper
• [Serotonin and blood pressure regulation--antihypertensive mechanism of ketanserin].

  1989cites this paper
• Quantitative autoradiographic mapping of serotonin 5‐HT1 and 5‐HT2 receptors and uptake sites in the neocortex of the rhesus monkey

  1989cites this paper
• Neurobiologische Aspekte psychischer Störungen bei degenerativen Hirnerkrankungen im Alter

  1989cites this paper
• An autoradiographic analysis of serotonin receptors in human temporal cortex: Changes in Alzheimer-type dementia.

  1988cites this paper
• What is the nature of the role of the serotonergic nervous system in learning and memory: prospects for development of an effective treatment strategy for senile dementia.

  1988cites this paper
• Neuropathological and Neurochemical Aspects of Alzheimer’s Disease

  1988cites this paper
• Age-related differential recovery rates of rat striatal D-1 dopamine receptors following irreversible inactivation.

  1988cites this paper
• Peripheral serotoninergic receptor sensitivity in senile dementia of the Alzheimer type.

  1988cites this paper
• Dementia in Parkinson’s Disease

  1988cites this paper
• Selective loss of serotonin recognition sites in the parietal cortex in Alzheimer's disease

  1988cites this paper
• Decrease of serotonin‐S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy

  1988cites this paper
• Receptors in human brain diseases: a use for receptor autoradiography in neuropathology.

  1988cites this paper
• Unaltered platelet [3H]-imipramine binding in dementia of the Alzheimer type.

  1988cites this paper
• Evidence of Glutamatergic Denervation and Possible Abnormal Metabolism in Alzheimer's Disease

  1988cites this paper
• Cholinergic systems and alzheimer's disease

  1988cites this paper